MENU

News Release

News Release

  • Home
  • News Release
  • Announcing the Start of Administration of Functional Peptide SR-0379 to Subjects in Phase III Clinical Trial

NEWS RELEASE

News Release

Announcing the Start of Administration of Functional Peptide SR-0379 to Subjects in Phase III Clinical Trial